While NuVasive shares lost 6.43 percent on a four-week basis, the shares are marginally negative as compared to the S&P 500 for the past week with a loss of 2.08 percent. The company has underperformed the index by 6.91 percent in the past four weeks.
The 52-week low of the share price is $31.35 and the percentage difference in the current price and the 52-week high is 9.04 percent, according to the report.
More articles on devices:
Smith & Nephew, Misonix, Precision Spine & more — 22 key notes
Smith & Nephew insider sells 11k+ shares
Wright Medical Group’s “neutral” rating reaffirmed by Zacks
